Guidelines for oxytocin administration after birth: AWHONN practice brief number 2

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 44, Issue 1, 2015, Pages 161-163

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN;

ADULT; CLINICAL NURSING RESEARCH; EDUCATION; EVIDENCE BASED NURSING; FEMALE; HUMAN; LABOR INDUCTION; NEWBORN; NEWBORN NURSING; NURSING; NURSING ASSESSMENT; NURSING ORGANIZATION; NURSING PRACTICE; NURSING STAFF; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PREGNANCY; PROCEDURES; STANDARDS; TOTAL QUALITY MANAGEMENT; UNITED STATES;

ADULT; CLINICAL NURSING RESEARCH; EVIDENCE-BASED NURSING; FEMALE; HUMANS; INFANT, NEWBORN; LABOR, INDUCED; NEONATAL NURSING; NURSE'S PRACTICE PATTERNS; NURSING ASSESSMENT; NURSING STAFF, HOSPITAL; OXYTOCIN; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; SOCIETIES, NURSING; TOTAL QUALITY MANAGEMENT; UNITED STATES;

EID: 84922986640     PISSN: 08842175     EISSN: 15526909     Source Type: Journal    
DOI: 10.1111/1552-6909.12528     Document Type: Article

References (22)

1. Butwick, A. J., Coleman, L., Cohen, S. E., Riley, E. T., & Carvalho, B. (2010). Minimum effective bolus dose of oxytocin during elective caesarean delivery. British Journal of Anaesthesia, 104(3), 338-343.
2. Callaghan, W. M., Kuklina, E. V, & Berg, C. J. (2010). Trends in postpartum hemorrhage: United States, 1994-2006. American Journal of Obstetrics and Gynecology, 202(4), 353.e1-353.e6. doi:10.1016/j.ajog.2010.01.011
3. California Maternal Quality Care Collaborative. (2010). OB hemorrhage toolkit. Stanford, CA: Author. Retrieved from: https://www.cmqcc.org/ob_hemorrhage
4. Cunningham, F., Leveno, K., Bloom, S., Spong, C. Y., & Dashe, J., Hoffman, B.L., ...Sheffield, J. S. (Eds.). (2014). Williams obstetrics. (24th Ed.). New York: McGraw-Hill Professional Publishing.
5. Devikarani, D., & Harsoor, S. S. (2010). Are we using right dose of oxytocin? Indian Journal of Anaesthesia, 54(5), 371-373.
6. Dyer, R. A., Butwick, A. J., & Carvalho, B. (2011). Oxytocin for labour and caesarean delivery: Implications for the anaesthesiologist. Current Opinions in Anaesthesiology, 24(3), 255-261. doi:10.1097/ACO.0b013e328345331c
7. George, R. B., McKeen, D., Chaplin, A. C., & McLeod, L. (2010). Up-down determination of the ED90 of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing cesarean delivery. Canadian Journal of Anesthesia, 57, 578-582.
8. Gizzo, S., Patrelli, T.S., Gangi, S.D., Carrozzini, M., Saccardi, C., & Zambon, A. (2013). Which uterotonic is better to prevent postpartum hemorrhage. Latest news in terms of clinical efficacy, side effects, and contradictions: A systemic review. Reproductive Sciences, 20, 1011-1019.
9. International Confederation of Midwives & International Federation of Gynaecologists and Obstetricians. (2003). Joint statement: Management of the third stage of labour to prevent post-partum haemorrhage. Retrieved from http://www.figo.org/files/figo-corp/docs/PPH%20Joint%20Statement.pdf
10. J.P.H. Pharmaceuticals. (2007). Pitocin. Prescribing information. Retrieved from http://www.parsterileproducts.com/products/brands/pitocin.php
11. King, K. J., Douglas, M. J., Unger, W., Wong, A., & King, R. A. (2010). Five unit bolus oxytocin at cesarean delivery in women at risk of atony: A randomized double blind controlled trial. Anesthesia and Analgesia, 111(6), 1460-1466.
12. National Institute for Health and Care Experience. (2014). Intrapartum care overview. London, UK: Author. Retrieved from http://pathways.nice.org.uk/pathways/intrapartum-care?fno=1#path=view%3A/pathways/intrapartum-care/normal-labour-and-birth.xml&content=view-index
13. Ricci, S. S., Kyle, T., & Carmen, S. (2013). Essentials of maternity, newborn, and women's health nursing. Philadelphia, PA: Lippincott. Williams, and Wilkins.
14. Sheldon, W. R., Durocher, J., Winikoff, B., Blum, J. & Trussell, J. (2013). How effective are the components of active management of the third stage of labor? BMC Pregnancy and Childbirth, 13(46), 1-8.
15. Simpson, K. R., & Creehan, P. A. (2013). AWHONN perinatal nursing. (4th ed.). Philadelphia, PA: Lippincott. Williams, and Wilkins.
16. Simpson, K. R., & Knox, G. E. (2009). Oxytocin as a high-alert medication: Implications for perinatal patient safety. American Journal of Maternal Child Nursing, 34(1), 8-15.
17. Sultani, H., Hutchon, D. R., & Poulose, T. A. (2010). Timing of prophylactic uterotonics for the third stage of labour after vaginal birth. Cochrane Database of Systematic Reviews, 8, CD006173. doi:10.1002/14651858.CD006173.pub2
18. Trioano, N. H., Chez, B. F., & Harvey, C. J. (2012). AWHONN high risk and critical care obstetrics. Philadelphia, PA: Lippincott, Williams, and Wilkins.
19. United States Agency for International Development. (2010). Active management of the third stage of labor for prevention of postpartum hemorrhage: A fact sheet for policy makers and program managers. Retrieved from http://www.k4health.org/toolkits/pc-mnh/active-management-third-stage-labor-amtsl-prevention-post-partum-hemorrhage-fact
20. Westoff, G., Cotter, A. M., & Tolosa, J. E. (2013). Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database of Systematic Reviews, 10, CD001808. doi:10.1002/14651858.CD001808.pub2
21. World Health Organization. (2006). Prevention of postpartum haemorrhage by active management of third stage of labour. MPS technical update. Geneva, Switzerland: Author. Retrieved from http://www.who.int/maternal_child_adolescent/documents/postpartum/en/
22. World Health Organization. (2012). WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva, Switzerland: World Health Organization. Retrieved from http://apps.who.int/iris/bitstream/10665/75411/1/9789241548502_eng.pdf